The Oncology Institute Inc. (TOI)
NASDAQ · Healthcare
The Oncology Institute Inc. Shareholder Equity 2020–2025
The Oncology Institute Inc. annual shareholder equity history from 2020 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- The Oncology Institute Inc. shareholder equity as of December 31, 2025: -15.7M, a 538.01% decrease year-over-year.
- The Oncology Institute Inc. shareholder equity for 2025 were -15.7M, a 538.01% decrease from 2024.
- The Oncology Institute Inc. shareholder equity for 2024 were 3.6M, a 93.71% decrease from 2023.
- The Oncology Institute Inc. shareholder equity for 2023 were 57.0M, a 53.70% decrease from 2022.
- The Oncology Institute Inc. shareholder equity for 2022 were 123.2M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| The Oncology Institute Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $-16 |
| 2024 | $4 |
| 2023 | $57 |
| 2022 | $123 |
| 2021 | $104 |
| 2020 | $28 |
The Oncology Institute Inc. Shareholder Equity — FAQ
The Oncology Institute Inc. (TOI) shareholder equity over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see TOI's shareholder equity history?
The chart and table above show The Oncology Institute Inc.'s shareholder equity by year and by quarter, including the growth rate.